R F Loeser1, W Pathmasiri2, S J Sumner2, S McRitchie2, D Beavers3, P Saxena3, B J Nicklas3, J Jordan4, A Guermazi5, D J Hunter6, S P Messier7. 1. Thurston Arthritis Research Center, Division of Rheumatology, Allergy, and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA. Electronic address: richard_loeser@med.unc.edu. 2. NIH Eastern Regional Comprehensive Metabolomics Resource Core, RTI International, Research Triangle Park, NC, USA. 3. Departments of Public Health Sciences and Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. 4. Thurston Arthritis Research Center, Division of Rheumatology, Allergy, and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA. 5. Department of Radiology, Boston University School of Medicine, Boston, MA, USA. 6. Rheumatology Department, Royal North Shore Hospital and Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, NSW, Australia. 7. Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, USA.
Abstract
INTRODUCTION: Metabolic factors may contribute to osteoarthritis (OA). This study employed metabolomics analyses to determine if differences in metabolite profiles could distinguish people with knee OA who exhibited radiographic progression. METHODS: Urine samples obtained at baseline and 18 months from overweight and obese adults in the Intensive Diet and Exercise for Arthritis (IDEA) trial were selected from two subgroups (n = 22 each) for metabolomics analysis: a group that exhibited radiographic progression (≥0.7 mm decrease in joint space width, JSW) and an age, gender, and body mass index (BMI) matched group who did not progress (≤0.35 mm decrease in JSW). Multivariate analysis methods, including orthogonal partial least square discriminate analysis, were used to identify metabolite profiles that separated progressors and non-progressors. Plasma levels of IL-6 and C-reactive protein (CRP) were evaluated as inflammatory markers. RESULTS: Multivariate analysis of the binned metabolomics data distinguished progressors from non-progressors. Library matching revealed that glycolate, hippurate, and trigonelline were among the important metabolites for distinguishing progressors from non-progressors at baseline whereas alanine, N,N-dimethylglycine, glycolate, hippurate, histidine, and trigonelline, were among the metabolites that were important for the discrimination at 18 months. In non-progressors, IL-6 decreased from baseline to 18 months while IL-6 was unchanged in progressors; the change over time in IL-6 was significantly different between groups. CONCLUSION: These findings support a role for metabolic factors in the progression of knee OA and suggest that measurement of metabolites could be useful to predict progression. Further investigation in a larger sample that would include targeted investigation of specific metabolites is warranted.
INTRODUCTION: Metabolic factors may contribute to osteoarthritis (OA). This study employed metabolomics analyses to determine if differences in metabolite profiles could distinguish people with knee OA who exhibited radiographic progression. METHODS: Urine samples obtained at baseline and 18 months from overweight and obese adults in the Intensive Diet and Exercise for Arthritis (IDEA) trial were selected from two subgroups (n = 22 each) for metabolomics analysis: a group that exhibited radiographic progression (≥0.7 mm decrease in joint space width, JSW) and an age, gender, and body mass index (BMI) matched group who did not progress (≤0.35 mm decrease in JSW). Multivariate analysis methods, including orthogonal partial least square discriminate analysis, were used to identify metabolite profiles that separated progressors and non-progressors. Plasma levels of IL-6 and C-reactive protein (CRP) were evaluated as inflammatory markers. RESULTS: Multivariate analysis of the binned metabolomics data distinguished progressors from non-progressors. Library matching revealed that glycolate, hippurate, and trigonelline were among the important metabolites for distinguishing progressors from non-progressors at baseline whereas alanine, N,N-dimethylglycine, glycolate, hippurate, histidine, and trigonelline, were among the metabolites that were important for the discrimination at 18 months. In non-progressors, IL-6 decreased from baseline to 18 months while IL-6 was unchanged in progressors; the change over time in IL-6 was significantly different between groups. CONCLUSION: These findings support a role for metabolic factors in the progression of knee OA and suggest that measurement of metabolites could be useful to predict progression. Further investigation in a larger sample that would include targeted investigation of specific metabolites is warranted.
Authors: Elizabeth W Karlson; Lisa A Mandl; Gideon N Aweh; Oliver Sangha; Matthew H Liang; Francine Grodstein Journal: Am J Med Date: 2003-02-01 Impact factor: 4.965
Authors: A W Visser; R de Mutsert; M Loef; S le Cessie; M den Heijer; J L Bloem; M Reijnierse; F R Rosendaal; M Kloppenburg Journal: Osteoarthritis Cartilage Date: 2013-12-12 Impact factor: 6.576
Authors: Gregory Livshits; Guangju Zhai; Deborah J Hart; Bernet S Kato; Huizhong Wang; Frances M K Williams; Tim D Spector Journal: Arthritis Rheum Date: 2009-07
Authors: Stephen P Messier; Richard F Loeser; Gary D Miller; Timothy M Morgan; W Jack Rejeski; Mary Ann Sevick; Walter H Ettinger; Marco Pahor; Jeff D Williamson Journal: Arthritis Rheum Date: 2004-05
Authors: P M Jungmann; M S Kraus; H Alizai; L Nardo; T Baum; M C Nevitt; C E McCulloch; G B Joseph; J A Lynch; T M Link Journal: Arthritis Care Res (Hoboken) Date: 2013-12 Impact factor: 4.794
Authors: W Zhang; G Sun; S Likhodii; M Liu; E Aref-Eshghi; P E Harper; G Martin; A Furey; R Green; E Randell; P Rahman; G Zhai Journal: Osteoarthritis Cartilage Date: 2015-12-18 Impact factor: 6.576
Authors: A Willemien Visser; Andreea Ioan-Facsinay; Renée de Mutsert; Ralph L Widya; Marieke Loef; Albert de Roos; Saskia le Cessie; Martin den Heijer; Frits R Rosendaal; Margreet Kloppenburg Journal: Arthritis Res Ther Date: 2014-01-22 Impact factor: 5.156
Authors: Guangju Zhai; Xianbang Sun; Edward W Randell; Ming Liu; Na Wang; Irina Tolstykh; Proton Rahman; James Torner; Cora E Lewis; Michael C Nevitt; Ali Guermazi; Frank Roemer; David T Felson Journal: J Rheumatol Date: 2020-05-01 Impact factor: 4.666
Authors: Salah Ali A Showiheen; Antonia RuJia Sun; Xiaoxin Wu; Ross Crawford; Yin Xiao; R Mark Wellard; Indira Prasadam Journal: Curr Rheumatol Rep Date: 2019-05-06 Impact factor: 4.592
Authors: R F Loeser; D P Beavers; A C Bay-Jensen; M A Karsdal; B J Nicklas; A Guermazi; D J Hunter; S P Messier Journal: Osteoarthritis Cartilage Date: 2017-07-27 Impact factor: 6.576
Authors: A K Carlson; R A Rawle; C W Wallace; E G Brooks; E Adams; M C Greenwood; M Olmer; M K Lotz; B Bothner; R K June Journal: Osteoarthritis Cartilage Date: 2019-04-25 Impact factor: 6.576
Authors: B R Rushing; S McRitchie; L Arbeeva; A E Nelson; M A Azcarate-Peril; Y-Y Li; Y Qian; W Pathmasiri; S C J Sumner; R F Loeser Journal: Osteoarthritis Cartilage Date: 2021-10-28 Impact factor: 6.576
Authors: Alyssa K Carlson; Rachel A Rawle; Erik Adams; Mark C Greenwood; Brian Bothner; Ronald K June Journal: Biochem Biophys Res Commun Date: 2018-03-24 Impact factor: 3.575